Semin Oncol. 1992 Jun;19(3 Suppl 8):14-8.

The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.

Source

Cardeza Foundation for Hematologic Research, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.

Abstract

Recombinant human erythropoietin (r-HuEPO) has been shown to be remarkably effective in raising the hemoglobin concentrations and improving the quality of life of patients with chronic renal disease. It is currently under investigation for treatment of patients with nonrenal anemias associated with cancer chemotherapy, acquired immunodeficiency syndrome, rheumatoid arthritis, and other chronic illnesses. To date, investigators have shown that patients with mild anemia and low endogenous erythropoietin (EPO) production may be good candidates for such treatment. Conversely, studies have shown that patients with severe anemia and serum EPO concentrations of above 500 mU/mL apparently do not respond to doses used for patients with mild anemia or chronic renal disease. Large doses of r-HuEPO may be of use in such patients, and clinical trials are in progress to determine if it is at least possible to make these patients transfusion-independent.

PMID:: 1615334; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Medical

Anemia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review The application of recombinant erythropoietin in anemic patients with cancer. [Semin Oncol. 1992]
Review The application of recombinant erythropoietin in anemic patients with cancer.
Spivak JL. Semin Oncol. 1992 Jun; 19(3 Suppl 8):25-8.
The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. [J Pak Med Assoc. 1998]
The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G. J Pak Med Assoc. 1998 May; 48(5):127-31.
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. [Arch Intern Med. 1993]
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP, Abels RI, McNeill MV, Sullivan DJ. Arch Intern Med. 1993 Dec 13; 153(23):2669-75.
Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. [Semin Oncol. 1992]
Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer.
Abels RI. Semin Oncol. 1992 Jun; 19(3 Suppl 8):29-35.
Review Erythropoietin and the anaemia of chronic disease. [Nephrol Dial Transplant. 1995]
Review Erythropoietin and the anaemia of chronic disease.
Krantz SB. Nephrol Dial Transplant. 1995; 10 Suppl 2:10-7.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The therapeutic role of recombinant erythropoietin in anemic patients with intac...
The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
Semin Oncol. 1992 Jun ;19(3 Suppl 8):14-8.

PubMed
The National Food Consumption Survey (NFCS): South Africa, 1999.
The National Food Consumption Survey (NFCS): South Africa, 1999.
Public Health Nutr. 2005 Aug ;8(5):533-43.

PubMed
Are Biomphalaria snails resistant to Schistosoma mansoni?
Are Biomphalaria snails resistant to Schistosoma mansoni?
J Helminthol. 2005 Sep ;79(3):187-91.

PubMed
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumo...
Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.
Mol Cancer. 2005 Sep 9 ;4:33.

PubMed
Translational regulation of GCN4 and the general amino acid control of yeast.
Translational regulation of GCN4 and the general amino acid control of yeast.
Annu Rev Microbiol. 2005 ;59:407-50.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: